Moscovitz Jamie E, Aleksunes Lauren M
Department of Pharmacology and Toxicology, Rutgers University Ernest Mario School of Pharmacy, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.
Int J Mol Sci. 2013 Dec 6;14(12):23801-27. doi: 10.3390/ijms141223801.
The ultimate fate of drugs and chemicals in the body is largely regulated by hepatic uptake, metabolism, and excretion. The liver acquires the functional ability to metabolize and transport chemicals during the perinatal period of development. Research using livers from fetal and juvenile rodents and humans has begun to reveal the timing, key enzymes and transporters, and regulatory factors that are responsible for the establishment of hepatic phase I and II metabolism as well as transport. The majority of this research has been limited to relative mRNA and protein quantification. However, the recent utilization of novel technology, such as RNA-Sequencing, and the improved availability and refinement of functional activity assays, has begun to provide more definitive information regarding the extent of hepatic drug disposition in the developing fetus. The goals of this review are to provide an overview of the early regulation of the major phase I and II enzymes and transporters in rodent and human livers and to highlight potential mechanisms that control the ontogeny of chemical metabolism and excretion pathways.
药物和化学物质在体内的最终命运很大程度上受肝脏摄取、代谢和排泄的调节。肝脏在围产期发育过程中获得代谢和转运化学物质的功能能力。使用来自胎儿和幼年啮齿动物及人类肝脏的研究已开始揭示负责建立肝脏I相和II相代谢以及转运的时间、关键酶和转运蛋白,以及调节因子。这项研究大多局限于相对mRNA和蛋白质定量。然而,最近新技术的应用,如RNA测序,以及功能活性测定的可用性提高和改进,已开始提供有关发育中胎儿肝脏药物处置程度的更确切信息。本综述的目的是概述啮齿动物和人类肝脏中主要I相和II相酶及转运蛋白的早期调节,并强调控制化学物质代谢和排泄途径个体发生的潜在机制。